ENA 50 Pill - yellow oval, 12mm
Generic Name: enasidenib
Pill with imprint ENA 50 is Yellow, Oval and has been identified as Idhifa 50 mg. It is supplied by Celgene Corporation.
Idhifa is used in the treatment of Acute Myeloid Leukemia and belongs to the drug class miscellaneous antineoplastics. Idhifa 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ENA 50
Idhifa
- Generic Name
- enasidenib
- Imprint
- ENA 50
- Strength
- 50 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0705
- Inactive Ingredients
-
microcrystalline cellulose,
sodium starch glycolate type A potato,
sodium lauryl sulfate,
hypromellose acetate succinate,
silicon dioxide,
magnesium stearate,
polyvinyl alcohol,
titanium dioxide,
polyethylene glycol,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "ENA 50"
More about Idhifa (enasidenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
